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INTRODUCTION 
 
 A myopathy is a muscular disease in which the muscle fibers do not function 
resulting in muscular weakness. "Myopathy" simply means muscle disease  
(myo- Greek μυο "muscle" + pathos -pathy Greek "suffering").  
 There are two class of myopathy: congenital and acquired. Among congenital 
myopathy, particularly, there is a class of metabolic myopathy caused by a difect in 
lysosomal function, these are called ”Lysosomal Storage Disease”. Lysosomal storage 
diseases are a group of more than 45 genetically determined heterogenous metabolic 
disorders.  
 The majority are characterized by deficient activity of specific lysosomal 
hydrolases and the intralysosomal accumulation of one or more substrates in affected 
cells.   
 These vacuolar myopathies are defined by the presence within myofibers of 
circumscribed spaces called vacuoles. Vacuolar pathology is one of the most common 
pathologies in skeletal muscle disease. 
 
1.1. Autophagic Vacuolar Myopathies 
 
 Autophagic Vacuolar Myopathies (AVMs) are an emerging group of conditions 
characterized by presence in the sarcoplasm of large, membrane-bound true vacuoles 
(not artifacts of tissue preparation) filled with partially degraded cellular components 
including proteins, glycogen, and degenerating organelles (1). 
 The presence of varied cytoplasmic constituents in partially degraded state 
 A Spontaneous Mouse Model of X-Linked Myopathy with Excessive Autophagy 
 
 
5
within the vacuoles led to terming these vacuoles, and the diseases, “Autophagic”.  
Currently there are different AVMs (Table 1). 
 
Table 1. Autophagic vacuolar myopathies  
DISEASE NAME REFERENCE 
Danon Disease Danon MJ et al.(1981) 
Pompe Disease Pompe JC(1932) 
X-linked  myophaty with excessive autophagy Kalimo H et al.(1988) 
Infantile autophagic vacuolar myopathy Yamamoto A et al.(2001) 
Childhood autophagic vacuolar myopathy Yan C et al.(2005) 
Autophagic vacuolar myopathy with multiorgan 
involvement 
Kaneda D et al.(2003) 
Autophagic vacuolar myopathy with dilated 
cardiomyopathy 
Sugimoto S et al.(2007) 
 
 The origin of the vacuolar membrane in AVMs is unknown.  
A subgroup of AVMs is characterized by vacuoles possessing sarcolemmal features 
(AVSF). Sarcolemma is the plasma membrane of the myofiber and is surrounded by the 
extracellular matrix, called basement membrane, with two layers: the basal lamina, in 
direct contact with the sarcolemma, and the outer reticular lamina (fig.1).  
The membrane of vacuoles with sarcolemmal features displays proteins that are 
otherwise localized to the intracellular face of sarcolemma and on the basal lamina, such 
as, but not restricted to, dystrophin and laminin α2. Of the AVSFs, the most frequent are 
Danon disease and X-linked myopathy with excessive autophagy (XMEA), the latter 
representing the focus of this thesis. 
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Fig.1: Sarcolemma and basement membrane-associated proteins 
The dystrophin-associated protein complex (DPC) in skeletal muscle. Dystrophin binds 
to cytoskeletal actin at its NH2 terminus. At its COOH terminus, dystrophin is 
associated with a number of integral and peripheral membrane proteins that can be 
classified as the dystroglycan subcomplex, the sarcoglycan-sarcospan subcomplex, and 
the cytoplasmic subcomplex. The cytoplasmic subcomplex includes the syntrophins 
(syn) and -dystrobrevin (DB). The sarcoglycan-sarcopsan subcomplex comprises the 
sarcoglycans and sarcospan. The extracellular component of the dystroglycan complex, 
-dystroglycan (DG), binds to laminin-2 in the extracellular matrix and -dystroglycan 
(DG) in the sarcolemma. In turn, -dystroglycan binds to the dystrophin, thus completing 
the link between the actin-based cytoskeleton and the extracellular matrix. 
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Acid maltase deficiency (Pompe disease) 
  
 Pompe disease (glycogen storage disease type II) is an autosomal recessive 
disorder which damages muscle and nerve cells throughout the body. It is caused by an 
accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid 
maltase, an enzyme which catalyzes the hydrolysis of α-1,4 and α-1,6 links of glycogen. 
As a result, glycogen accumulates inside lysosomes, primarily in cardiac and skeletal 
muscle (fig.2). Complete acid maltase deficiency causes a rapidly progressing disease in 
infants, who die of cardiac failure before age 2. Partial deficits lead to late-onset forms, 
when cardiac muscle is usually spared and the phenotype is dominated by a slowly 
progressive myopathy with respiratory insufficiency. Microscopic examination of 
muscle biopsy shows variable-sized vacuoles that are strongly positive for the 
lysosomal acid phosphatase, indicative of lysosomes, predominantly in type I fibers. 
Although in some late-onset forms the vacuolar membrane may react with markers of 
dystrophin, this feature is not constant and does not include many sarcolemmal and 
basal lamina proteins. There is diffuse increase in glycogen staining in muscle and acid 
maltase activity is reduced or absent. Recent results show that in Pompe disease, all the 
vesicles of the endocytic/autophagic pathways rather than just lysosomes are 
dramatically expanded and less mobile, while a subset of late endosomes/lysosomes 
have increased pH. These findings suggest that Pompe lysosomes, apart from lacking 
acid maltase, also have a defect in fusing with and cause hydrolases to autophagic 
vacuoles (2). 
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Fig.2: Pompe disease pathway 
Glycogen builds up in cells and is taken up by the lysosomes. 
 In Pompe disease, it cannot be broken down into glucose and therefore accumulates in 
the lysosomes, causing tissue damage. 
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Danon disease 
  
 Danon disease was the first AVM-SF described by Moris Danon in 1981.  
 The phenotype is characterized by the triad cardiomyopathy, myopathy and 
mental retardation.  
 Inheritance is X-linked, with males being affected predominantly, while carrier 
mothers usually have milder and later-onset cardiac symptoms. Muscle biopsy is 
diagnostic and shows vacuoles containing cellular debris, including cytoplasmic 
degradation products and glycogen.  
 The vacuolar membrane is positive for dystrophin and delineated by basal 
lamina. 
Nishino et al. (3) showed that Danon disease is caused by inactivating mutations in the 
LAMP2B isoform of the LAMP2 gene (lysosomal-associated membrane protein) on 
chromosome Xq24, encoding a lysosomal membrane protein (3). In the absence of 
LAMP2B, lysosomes appear unable to merge with and provide enzymes to autophagic 
vacuoles (4). As a result, autophagosome maturation is impaired and they accumulate in 
the cytosol (5). A LAMP2-deficient mouse has been created that proved a valuable 
model of Danon disease. These mice show extensive accumulation of autophagic 
vacuoles in many tissues including liver, pancreas, spleen and kidney, beside heart and 
skeletal muscle (6). 
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 Infantile autophagic vacuolar myopathy (AVM-I) 
 
 Two vacuolar myopathy patients with unusually severe phenotype and early 
onset were reported by Yamamoto et al. (7). Both patients were hypotonic at birth, 
presented with cardiomegaly and died in early infancy. Acid maltase and LAMP-2 
staining were positive in heart, skeletal muscle and liver that contain glycogen granules. 
 Pathological examination showed a picture similar to XMEA because these the 
two diseases are allelic. 
 
 
Childhood autophagic vacuolar myopathy with sarcolemmal features (C-AVM-SF) 
  
 In 2005, Yan et al. (8) reported a large family with a different phenotype than 
known AVMSFs. 
 The family included seven affected male members of Chinese-American 
background. Of these, five died during infancy. The surviving two members were 
hypotonic infants and developed cardiomyopathy, dyspnea and dysphagia. Serum 
creatine kinase levels were elevated. Muscle pathology revealed autophagic vacuoles 
with sarcolemmal features, multilayered basal lamina with marked sarcolemmal 
deposition of C5-b9 membrane attack complex and calcium, histologically 
indistinguishable from childhood-onset X-linked myopathy with excessive autophagy 
(XMEA).  
 No female relatives, including the carriers, were affected. Haplotype analysis 
suggests that this new AVM and XMEA may be allelic despite different clinical 
presentations.  
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Autophagic vacuolar myopathy with multiorgan involvement (AVM-Mo) 
 
 Kaneda et al. (9) reported a 41-year-old man with a novel form of adult-onset 
autophagic vacuolar myopathy (AVM) with multiple organ involvement including eyes, 
heart, liver, lung, kidney, and skeletal muscle. Serum creatine kinase was slightly 
elevated. The vacuolar membranes had sarcolemmal features similar to vacuoles in 
Danon disease, X-linked myopathy with excessive autophagy, and infantile AVM. 
 Lysosome associated membrane protein-2, absent in Danon disease, was present. 
Vacuolation was also present in heart and liver. Defined by distinct clinical features, 
this disease constitutes the fourth entity in the group of autophagic vacuolar myopathy 
in which the vacuolar membranes have features of sarcolemma. 
 The disease-causing gene in congenital AVM is not known at the present time. 
 
Autophagic vacuolar myopathy with dilated cardiomyopathy 
  
 Recently, a late-onset case of AVM with cardiomyopathy of the dilated type was 
reported by Sugimoto et al. (10). The patient, of Japanese background, came from a 
family with history of consanguineous marriage. Unlike previously-described late-onset 
AVM, other organs beside muscle were unaffected. Serum creatine kinase was ~ 10 
times above normal values. Acid maltase activity of the muscle was normal, but the 
biopsied muscle specimen stained for lysosome-associated membrane protein-2 
(LAMP-2), which has been reported to be deficient in muscles of patients with Danon 
disease. The clinical features of the patient are distinct from X-linked myopathy with 
excessive autophagy, infantile autophagic vacuolar myopathy and autophagic vacuolar 
myopathy with late-onset and multiorgan involvement. 
 The gene defect responsible is not known. 
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1.2. Differential diagnosis of AVMs 
  
 AVM entities can be separated from one another based on clinical and 
pathological criteria (Table 2) 
 
Table 2. Differential diagnosis of AVMs 
 
 
 Pompe 
disease 
Danon 
disease 
XMEA Infantile
AVM 
Childhood
AVM 
AVM with 
multiorgan 
involvment 
AVM with 
dilatated 
cardiomyopathy
Myopathy onset Infancy 
and 
adulthood 
Teenage 
years 
6-18 
years 
infancy Early 
childhood 
adulthood adulthood 
Myopathy 
severity 
Respiratory 
muscles 
involved 
mild mild Early 
death 
Early 
death in 
same cases
mild mild 
Cardiomiopathy + + - + +/- + + 
Mental 
retardation 
- + - NA - - - 
Other organs 
involved 
- + - NA - + - 
LAMP2 protein + - + + + + + 
Acid maltase - + + + + + + 
Vacuoles with 
sarcolemmal 
features 
- + + + + + + 
Basement 
membrane 
duplication 
- - + + + - NA 
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2. Autophagy 
  
 The term “autophagy”, coming from the Greek words for “eating oneself”, refers 
to any process of degradation of intracellular components by lysosomes.  
Three types of autophagy (fig.3) have been described to date: 
- In chaperone-mediated autophagy, the lysosome takes in proteins to be digested via 
specific receptors 
-Microautophagy happens when lysosomes directly engulf cytoplasm by invaginating, 
protrusion, and/or septation of the lysosomal limiting membrane. 
-Macroautophagy is responsible for the bulk degradation of long-lived proteins and 
aged organelles . 
Macroautophagy sequestrates damaged organelles and unused long-lived proteins in a 
double-membrane vesicle, called an autophagosome or autophagic vacuole (AV), inside 
the cell. Autophagosomes form from the elongation of small membrane structures 
known as autophagosome precursors. Increased macroautophagy means increased 
formation of autolysosomes, but in XMEA each new autolysosome undergoes a 
degradative block and is slow to progress and disappear. Increased formation coupled 
with delayed progression results in vast numbers of autolysosomes, in some cells fusing 
together and forming giant autophagic vacuoles and autophagic vacuolation identical to 
the disease in muscle that gives XMEA its name, ‘‘excessive autophagy’’ (11). 
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Fig.3: Macro and Microautophagy 
In microautophagy, organelles and/or cytosolic proteins are engulfed by the vacuolar 
membrane and degraded in the vacuole lumen. Macroautophagy involves the formation 
of large (300-900 nm) cytosolic, double-membrane vesicles (autophagosomes), which 
sequester organelles and/or cytosolic proteins. Once formed, autophagosomes fuse with 
the vacuole, releasing a single-membrane vesicle (autophagic body) into the lumen of 
this organelle where the autophagic bodies are degraded 
 
2.1. Autophagy - a housekeeping process 
  
 Autophagy have different functions: nutrient starvation, infection, repair 
mechanism and programmed cell death. 
 Autophagy was initially described as a particular adaptation response of the cell 
to starvation: when external nutrients become limited, the cell continues to maintain 
energy production and macromolecular synthesis by digesting and re-utilizing old or 
non-essential cellular components.  
 Autophagy plays a role in the destruction of some bacteria within the cell. 
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Intracellular pathogens such as Mycobacterium tuberculosis persist within cells and 
block the normal actions taken by the cell to rid itself of it. Stimulating autophagy in 
infected cells overcomes the block and helps to rid the cell of pathogens. 
 Autophagy degrades damaged organelles, cell membranes and proteins, and the 
failure of autophagy is thought to be one of the main reasons for the accumulation of 
cell damage and aging. 
 Autophagy occurs with formation of a transient organelle called 
“autophagosome”, a double-membrane vacuole that delivers the components to be 
destroyed to the lysosome.  
 The origin of the autophagosomal membrane is controversial; it arises as a 
membrane sac (phagophore) that expands around a cytosol portion containing the 
target. The autophagosomes merge with lysosomes and become autolysosomes, which 
possess lysosomal pH and acid hydrolases (12). Lysosomal enzymes rapidly degrade 
the vacuolar content along with the inner membrane layer and the autolysosome is 
cleared from the cytosol (fig. 4). The process ends up when the remaining lysosome 
releases for recycling, through lysosomal membrane permeases, macromolecules 
resulted from digestion. As basal autophagy takes place at a low rate, microscopic 
observation of autophagic vacuoles in healthy tissues is a rare instance. Regulation of 
autophagy is extremely complex and involves pathways overlapping with control of cell 
growth, proliferation, cell survival and death. 
 A Spontaneous Mouse Model of X-Linked Myopathy with Excessive Autophagy 
 
 
16
 
Fig.4:Autophagosome formation and clearance 
(a, b) Cytosolic material is sequestered by an expanding membrane sac, the 
phagophore;  
(c) resulting in the formation of a double-membrane vesicle, an autophagosome;  
(d) the outer membrane of the autophagosome subsequently fuses with a lysosome, 
exposing the inner single membrane of the autophagosome to lysosomal hydrolases; 
 (e) the cargo-containing membrane compartment is then lysed, and the contents are 
degraded. 
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2.2. Autophagy – the lysosomal component 
 
 The lisosome is the primary disposal and recycling apparatus of the cell. It 
degrades cellular and extracellular macromolecules, providing aminoacids, fatty acids, 
nucleic acids, and carbohydrate residues for reutilization in cellular synthesis. DeDuve 
coined the term lysosome in Greek meaning “litic body”, in 1955 to describe a 
sedimentable acidified cytoplasmic organelle containing various hydrolases that degrade 
cellular and extracellular products and foreign materials ingested by the cell(fig.5).   
 The lysosomal membrane protects the cell from the destructive action of the 
degradative enzyme within it (6). 
 To begin the process of intracellular digestion, a hydrolase-free  vacuoles 
containing macromolecular material coalesces, via the lysosomial associated protein-2 
(LAMP-2). The vacuoles contain intracellular debris (autophagy) or extracellular 
foreign (eterophagy).  
 Following digestion of the macromolecules, their individual components are 
transported to the cytosol for reutilization. These dense polymorphic bodies are able to 
leave the cell to be taken up by other cells and for the extracellular digestion of 
connective tissue and bone. Lysosomial enzymes are glycoproteins that act on lipids, 
carbohydrates, proteins, and nucleotides to catalyze irreversibly their hydrolysis to their 
basic structural units. The genes coding for many of these enzymes have been mapped 
to specific human chromosomes. Lysosomes contain up to 50 types of acid hydrolases, 
including proteases, nucleases, glycosidases, lipases, phospholipases, phosphatases and 
sulphatases. These enzymes are synthesized in the endoplasmic reticulum (ER) and a 
hydrophobic aminoterminal signal peptide on the nascent protein directs its transport 
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into the lumen of the RER, where it undergoes glycosylation of selected asparagines 
residues. Maturation of lysosomal enzymes is a three-step process depending on 
successively lower pH: mannose 6-phosphorylation in the Golgi (pH 6.5), removal of 
mannose in endosomes (pH 5.5) that transport the enzymes to the lysosome, and finally 
cleavage of preproteins into shorter active forms in the lysosome (pH 4.7). 
 Lysosomal pH is critical for optimal activity of acid hydrolases. It is mainly 
controlled by an ATP-consuming complex, the vacuolar ATP-ase (V-ATPase). 
  The  lysosomal protein in a vesicular form then enters the Golgi apparatus where 
a series of covalent modifications occur to the transported proteins. The pathway and 
targeting signal for lysosomal membrane proteins differs from those used by soluble 
lysosomal hydrolases. The two best-know lysosomal–associated membrane proteins 
(LAMP) are LAMP-1 and LAMP-2. These two glycoproteins are structurally similar 
and evolutionarily related. Expression of LAMP-2 is increased in tissues of mice 
deficient in LAMP-1. LAMP-2  is a family of membrane proteins, and LAMP-2a was 
identified as a receptors in lysosomes known as chaperone-mediated autophagy. Recent 
studies indicate that LAMP-2 may be involved in the process of fusion of autophagic 
vacuoles with lysosomes.  
 Lysosomal disorders are triggered when a particular enzyme exists in asmall 
amount or is entirely missing. When this happens, substances accumulate in the cell.  
In other words, when the lysosome doesn’t function normally, excess products destined 
for breakdown and recycling are stored in the cell. Clinically, the initial manifestations 
begin in childhood and, in many of these disorders, death can occur at an early age. In 
many, the central nervous system is particularly affected, because neurons whose 
function is impaired by lysosomal storage lack the ability to regenerate. 
 Nearly all lysosomal storage diseases are inborn errors of metabolism. The 
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majority are inherited as autosomal recessive traits. For many of the diseases, severe 
infantile, less severe juvenile, and milder chronic or late-onset forms are known.  
Such individuals are totally deficient in the relevant enzyme activity and usually have a 
severe clinical form of the disease. Muscle cells in patients with lysosomal diseases tend 
to shrink because of central nervous system degeneration, with resulting denervation.  
 There is loss of contractile elements and exocitisis of their lysosomal content. 
Thus, standard light microscopy of muscle is not very useful for the diagnosis of the 
majority of  lysosomal storage diseases because of relative size, amount, and solubility 
of the storage material. 
 Most of these disorders are autosomal recessively inherited however a few are 
X-linked recessively inherited (6). 
 
Fig.5: Anatomy of the Lysosome 
lysosomes are spherical organelles contained by a single layer membrane, though their 
size and shape varies to some extent. This membrane protects the rest of the cell from 
the harsh digestive enzymes contained in the lysosomes, which would otherwise cause 
significant damage. The cell is further safeguarded from exposure to the biochemical 
catalysts present in lysosomes by their dependency on an acidic environment. 
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2.3. Autophagy in skeletal muscle 
 
 The lysosomal system in normal skeletal muscle is poorly developed. One 
possible reason is that muscle does not normally engage in absorptive, secretory, or 
excretory activities. Normal skeletal muscle contains a full complement of acid 
hydrolases. There are two populations of lysosomes in skeletal muscle. Those from the 
muscle itself account for 75 to 95 percent of the enzyme activity. Lysosomal enzyme 
activities are higher in fetal muscle and muscle of young animals than in muscle of 
older animals. Histochemical studies demonstrate greater activity in the oxidative than 
in the glycolytic fibers (6). 
 As discussed above, the autophagic process depends on regulated ATG genes 
and, at the other end, on lysosomes being able to fulfil their clearance function. Tissue 
vacuolation has been linked to either massive up-regulation of autophagy that 
overcomes lysosomal capacity of clearance, and/or to defective lysosomes that fail to 
clear even steady-state autophagosomes, although evidence of step-to-step processes 
leading to vacuolation is missing. 
 However, not every tissue is equally prone to vacuolation. Vacuolar myopathies 
are the most common muscle diseases, suggesting that muscle is particularly susceptible 
to deregulation of the autophagic process. This is further supported by the fact that 
muscle is preferentially affected in diseases caused by lysosomal defects, although the 
defect exists throughout the organism (like Danon disease and Pompe disease). Recent 
data confirm and help explain particularities of autophagy in muscle.  
Bechet et al. (13) reported that of all tissues, skeletal muscle has the fewest lysosomes. 
At the same time however, as shown by Mizushima et al. (2004), skeletal muscle has 
the highest macroautophagic activity after stimulation (14).  
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Interestingly, although stimulation of autophagy in muscle elicits an ample response in 
terms of autophasome numbers, the size of these is small, even smaller than 
autophagosomes in other tissues and very small compared to the giant autophagic 
vacuoles that characterize XMEA pathology (14). 
 
 
3. X-LINKED VACUOLAR MYOPATHY WITH EXCESSIVE AUTOPHAGY 
  
 In 1988, Kalimo et al. (15), described a new type of X-linked myopathy in a 
Finnish family. The clinical course was characterized by slow progression of muscle 
weakness without loss of ambulation in childhood and no evidence of cardiac, 
respiratory, or central nervous system involvement. Muscle fibers were not necrotic and 
showed excessive autophagic activity and exocytosis of the phagocytosed material. 
 These authors proposed the name X-linked myopathy with excessive autophagy 
(XMEA) (15). 
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3.1. Clinical presentation 
 
 XMEA usually begins in childhood, progresses slowly, and affects skeletal 
muscle exclusively. Patients have normal life expectancy. All affected patients are male. 
Obligate female carriers either are asymptomatic or manifest subtle clinical, 
electromyographic, or muscle biopsy findings. Typically, the onset is between ages 6 
and 18 years with weakness and gradual wasting of the proximal muscles of the lower 
extremities. The affected boy achieves all the normal motor milestones, followed by 
gradual inability to keep up with his companions in running and climbing.  
 Other skeletal muscle groups are progressively affected including the upper limb 
girdle and distal muscles. The typical clinical feature is slowly progressive proximal 
weakness, most marked in the lower limbs. Muscle fibers are not necrotic and show 
excessive autophagic activity and exocytosis of the phagocytosed material. Significant 
muscle wasting, most marked in the quadriceps, occur in adults. Cardiac muscle 
involvement is notably absent. Patients may become wheelchair-bound in their fifties, 
but lifespan is generally not affected. However, in some cases, life expectancy was 
shortened due to respiratory muscle involvement  (6). 
 The central and peripheral nervous system, heart and other organs are clinically 
unaffected. Generally, plasma levels of serum creatine kinase are considered 
proportional to the degree of muscle cell destruction by necrosis. The moderate increase 
in serum creatine kinase in XMEA however is not explained by the total lack of 
necrosis. Kalimo et. al suggested that it may arise by extrusion of creatine kinase 
molecules together with other exocytosed material once vacuoles fuse with the 
sarcolemma and open to the extracellular space (15). 
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3.2. Epidemiology 
 
 XMEA is rare and probably under-diagnosed. To date, few families have been 
reported and the ethnic backgrounds were different: Finnish, French, American, 
English, Kurdish, Armenian and Italian. The actual disease prevalence will become 
clear in the coming years with the availability of genetic testing. 
 
  
3.3 Electromyography 
 
 EMG consists in recording of the electrical activity of muscle by inserting a 
needle electrode in the muscular mass. Recordings are made while muscle is at rest, as 
well as during passive and active contractions. Various neuromuscular disorders 
determine specific electrical response patterns. A nerve conduction velocity test is 
usually performed at the same time, when small electrical shocks are applied to measure 
the ability of the nerve to conduct electrical signals. 
 In XMEA patients, nerve conduction studies are normal. EMG examination 
reveals myopathic changes, including striking myotonic and high-frequency discharges 
in all muscles, even clinically unaffected facial, bulbar and distal limb muscles (16). 
 Myotonia represents a state of hyperexcitability of muscle fibers in which a 
voluntary contraction or electromechanical stimulation can provoke trains of repetitive 
action potentials and causes a delay in relaxation after muscle contraction. It is a feature 
in human disorders caused by dysfunctions of ion channels in the muscle membrane. 
Interestingly however, the EMG aspect of myotonia in XMEA patients is not 
accompanied by clinical mytonia. This rare situation of EMG-without-clinical myotonia 
was only described in rare cases of myotonic dystrophy type 2, adult-onset acid maltase 
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deficiency myopathy, myositis and thyroid myopathy (19), all clinically different from 
XMEA. 
 In conclusion, EMG in XMEA is characteristic and can be used in conjunction 
with pathologic examination as a tool to distinguish XMEA from other myopathies and 
AVMs. 
 
 
3.4 Genetics 
  
 The first reported XMEA family (1988) originated from Finland. A four-
generation pedigree was assembled that showed 5 affected males and no affected 
females; the disease was carried on from generation II to generation IV through a 
female who had affected sons from two marriages. This pedigree strongly suggested an 
X-linked mode of inheritance (15). Myopathies known to be linked to the X 
chromosome at the time were Duchenne-Becker muscular dystrophy at Xq21, Emery-
Dreifuss muscular dystrophy in the distal part of Xq and Danon disease that was 
thought to be a more severe form of XMEA. Although clinical presentation was 
different in XMEA, the possibility of novel mutations with effect on other functional 
domains or only affecting particular tissue isoforms of these genes could not be 
excluded. 
 In 1988, Saviranta et al. (17) attempted a linkage study in the original Finnish 
family. They analyzed segregation of restriction fragment length polymorphisms 
belonging to 17 loci across the X chromosome in III-2 and her sons (4 informative 
meiosis). Based on these genotyping results, the authors further calculated logarithm of 
odds (LOD) scores for linkage between each of the loci and XMEA gene at different 
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recombination fractions. The most likely linkage for XMEA was obtained with marker 
DXS15 on the most distal chromosomal band, Xq28. This excluded allelism with 
Duchenne-Becker muscular dystrophy. However, the LOD score based on this only 
XMEA family at the time was too low to establish with certitude linkage to Xq28. 
  In 2000, two separate studies firmly confirmed that XMEA gene was indeed 
linked to Xq28. Villard et al. (18) used the reported French XMEA family to construct 
an exclusion map of the X chromosome by analyzing segregation of 32 polymorphic 
markers distributed evenly across the chromosome. The entire chromosome except 
Xq28 was excluded so the candidate gene may be located in chromosome Xq28. The 
gene appears to be close to the Emery-Dreifuss gene so they also sequenced the emerin 
gene, responsible for Emery-Dreifuss muscular dystrophy, in three patients from three 
different XMEA families, without finding mutations. These results excluded allelism 
between XMEA and Emery-Dreifuss muscular dystrophy . 
 They also sequenced two candidate genes: the bigly-can gene, BGN, which 
encodes a protein that links the sarcoglycan complex to the basal lamina, and  the gene 
for filamin A, which achors the plasma membrane to the extracellular matrix. Other 
sequenced candidate genes in the region are emerin, and LAMP-2 mutated in Danon 
disease (6). In parallel, Auranen et al. (18) genotyped members of a Danon disease 
family for markers spanning the entire X chromosome. Haplotype analysis of two 
affected brothers excluded the region telomeric to marker DXS8091 as carrying the 
disease gene, thus showing that XMEA and Danon are not allelic (the possibility that a 
very large gene that would span to the region outside Xq28 was considered and 
excluded based on genome analysis). Together, results from these two studies placed 
the XMEA gene in a region telomeric to marker DXS1193, spanning 10.5 cM.  
 Minassian et al. (18) collected seven new families in the following two years and 
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genotyped the family members for known and newly described markers across the 10.5 
cM XMEA region. Three families have proved informative: two French families with 
an identical haplotype in affected members telomeric to marker DXS10053 and an 
American family where a recombination event resulted in identical haplotypes in two 
affected brothers only telomeric to the same marker DXS10053. These observations 
allowed narrowing of the disease locus to a 4.37 Mb region telomeric to marker 
DXS10053. 
 Genetic analysis selected different candidates genes for XMEA in particular 
Ramachandran et al.(11) focuses their attention on LOC203547 . LOC203547 encodes 
for a 101 amino acid protein which is named VMA21. 
The LOC203547 has three exons and a 4.7 Kb tran script expressed in all tissues.  
The mutations consist of six different single-nucleotide substitutions.  
 
FIG.6:identification of XMEA gene 
 The first two, c.54 _27A/T and c.54 _27A/C, eliminate the A nucleotide predicted to 
define the first intron’s splice branch point. The third, c.163 +4A/G,removes the A in 
the +4 position after exon 2 that is required for optimal U1 small nuclear RNA (snRNA) 
binding during splicing. The fourth, c.164 _7T/G, disrupts the polypyrimidine tract in 
intron 2, which would reduce the U2AF splice factor binding efficiency. A fifth, 
c.272G/C, is in coding sequence replacing a glycine with alanine, but it also abolishes a 
predicted splice enhancer site. The sixth, c.*6A/G, is in the 30 untranslated region (U  
TR). 
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3.5. V-ATPase pump 
 
 Ramachandran  et al. in 2009 (11), show that XMEA is caused by hypomorphic 
alleles of the VMA21 gene, that VMA21 is the diverged human ortholog of the yeast 
Vma21p protein, and that like Vma21p it is an essential assembly chaperone of the V-
ATPase, the principal mammalian proton pump complex. The V-ATPase is a multi-
subunit enzymatic complex that accomplishes against-gradient transfer of [H+] ions 
across membranes using energy resulted by breakdown of ATP.  
 V-ATPases acidify lysosomes and regulate the pH of multiple systems in the 
cell, including the secretory pathway and the endovesicular system, which use gradated 
pH to accomplish stepwise modifications. 
 The V-ATPases (fig.7) are ubiquitous in endomembrane systems of all cells, and 
in humans and other species are also expressed at the plasma membrane of specialized 
cells that secrete acid (11). 
 The V-ATPase complex is composed of 14-to-date protein subunits, organized 
into a transmembrane domain (V0) and a peripheral domain (V1)(19). The a subunit of 
the V0 sector spans the membrane and forms within it two separate channels that are not 
continuous one with the other. One channel starts in the cytoplasm and ends within the 
membrane lipid bilayer, and the other starts from a different location in the lipid bilayer 
and opens in the organelle lumen. Protons enter from the cytoplasm into the first 
channel and exit within the bilayer. There, they load onto the side of a cylinder 
(composed of V0 subunits c, c’, c” and d) which rotates and transports them to the 
entrance of the second a channel, through which they exit into the organelle. The torque 
that rotates this cylinder is provided by the V1 complex, which generates the force by 
consuming ATP. 
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FIG.7: V-ATPase pump  
The vacuolar (V-)ATPase complex is composed of a peripheral domain (V1, shown in yellow 
and orange), which is responsible for ATP hydrolysis, and an integral domain (V0, shown in 
blue and grey), which is involved in proton translocation across the membrane1. The core of the 
V1 domain is composed of a hexameric arrangement of alternating A and B subunits, which 
participate in ATP binding and hydrolysis. The V0 domain includes a ring of proteolipid 
subunits (c, c' and c") that are adjacent to subunits a and e. The V1 and V0 domains are 
connected by a central stalk, composed of subunits D and F of V1 and subunit d of V0, and 
multiple peripheral stalks, composed of subunits C, E, G, H and the N-terminal domain of 
subunit a. Subunit a possesses two hemi-channels and a crucial buried Arg residue (R735), 
which are required for proton translocation across the membrane. The depiction of the N-
terminal domain of subunit a having two lobes comes from the observation that this domain 
interacts with subunits C and H near the membrane interface24, 102 and with the non-
homologous region of subunit A69, which appears from electron microscopy images to be 
located about two-thirds of the way up the outer surface of V1. It is likely that in the isolated V0 
domain13 the N-terminal domain of subunit a can interact with rotor subunits (such as subunit 
d) in the free V0 complex, which therefore prevents rotation and passive proton translocation 
through free V0. 
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V-ATPases are also expressed in the plasma membranes of specialized cells and 
contribute to multiple functions, such as renal acidification, bone resorption, sperm 
maturation, and control of cytoplasmic pH. 
 Mutations in cell-specific isoforms of V-ATPase subunits cause tissue-specific 
diseases. 
 V-ATPase function caused by mutations in an essential chaperone, VMA21, that 
result in muscle-specific disease in humans (20). 
 The Ramachandran et al.(11) show that VMA21 deficiency decreases V-ATPase 
activity, resulting in an increase in intralysosomal pH. This increase in pH impairs 
lysosomal action and blocks the autophagic degradation of proteins leading to 
accumulation of autophagosomes and autophagic vacuoles. 
 Ramachandran et al. further postulate that the block in autophagy would result in 
upregulation of macroautophagy.  
 In agreement with this notion, they did observe an increase in early components 
of the macroautophagic activation pathway including beclin-1, beclin-1-hVps34 
complexes, and LC3. They further propose that decreased recycling of excess and 
degraded proteins and the reduced liberation of amino acids enhances autophagy 
because a decrease in amino acids in the cytoplasm modulates the mTOR signaling 
pathway, which then upregulates macroautophagy (Fig. 8). 
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Fig.8: V-ATPase and Autophagy in Health and Disease 
(A) The chaperone VMA21 (red circle) binds to the c′′ subunit of the vacuolar-ATPase (V-
ATPase; dark green) in the endoplasmic reticulum and initiates assembly of the proton-
translocator domain (V0;pale green).VMA21chaperones V0 in COPII vesicles to the 
endoplasmic reticulum Golgi intermediate complex (ERGIC).VMA21 is not present in the Golgi 
apparatus, but it is here that V-ATPase assembly is completed by addition of the ATP-hydrolytic 
domain (V1;turquoise). Proton pumping by the V-ATPase is critical for regulating the pH of 
lysosomes. Fusion of lysosomes with autophagosomes generates autolysosomes that degrade 
target proteins and organelles. 
(B) In the disease X-linked myopathy with excessive autophagy (XMEA), deficiency of VMA21 
leads to failure of V0 assembly, reduced levels of V-ATPase, and a decrease in lysosomal pH 
that impairs lysosomal and autophagic digestion of cellular proteins and organelles. Decreased 
protein degradation in XMEA may lower intracellular levels of amino acids that modulate the 
Mtor signaling pathway, which, in turn, upregulates macroautophagy. This leads to excessive 
accumulation of autophagosomes, autolysosomes, and autophagic vacuoles and a muscle-
specific disease phenotype.  
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 Female carriers are unaffected, likely because muscle is a syncytium and half of 
the nuclei will produce normal amounts of VMA21 mRNA. To our knowledge, XMEA 
is the first disease in which total, not local, cellular V-ATPase activity is affected.  
 On the other hand, XMEA mutations do not completely eliminate V-ATPase 
activity. XMEA patients do not exhibit neurodevelopmental delay or clinically manifest 
skin and bone abnormalities, acidosis, or hearing loss, indicating that for the specialized 
a2-, a3-, and a4-containing V-ATPases the reduced V-ATPase assembly in XMEA does 
not reach a clinical threshold.The reduced V-ATPase activity in XMEA results in a rise 
in lysosomal pH from 4.7 to 5.2. 
 They also observed that partial inhibition of lysosomal hydrolases by leupeptin 
(a pH-independent inhibitor of lysosomal hydrolases) in control fibroblasts and 
lymphoblasts resulted in mTOR-mediated upregulation of microautophagy, reflected by 
proliferation of autolysosomes and autophagic vacuoles. 
 If the authors’ notion that macroautophagy in XMEA is enhanced by activation 
of mTOR is correct, then blocking this pathway to reduce autophagy may prove 
beneficial to patients. 
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3.6 Features of C57 mouse 
 
 C57BL/6, often referred to as "C57 black 6" or just "black 6" (standard 
abbreviation: B6) is a common inbred strain of laboratory mice (fig.9).  
 Mice of the major C57BL subtrains are black (nonagouti). The most common 
substrains are C57BL/6 and C57BL/10. They are named for their origin from black 
offspring of female number 57 to male number 52 of Miss Abby Lathrop's stock in the 
original mating by Clarence Cook Little in 1921.The same cross gave rise to strains 
C57L and C57BR. Female 58 mated with the same male gave rise to strain C58. Strains 
6 and 10 separated prior to 1937.  In 1946, to the Jackson Laboratory, Bar Harbor. It is 
probably the most widely used "genetic background" for genetically modified mice for 
use as models of human disease. Are often used as the host, recipient or background 
strain for generation of congenics carrying spontaneous or induced mutations.  
 They are the most widely used mouse strain, due to the availability of congenic 
strains, easy breeding, and robustness.  C57BL/6 mice have a dark brown, nearly black 
coat, and an easily irritable temperament. They have a tendency to bite, and cannot be 
handled like a typical pet mouse or more docile laboratory strains such as BALB/c. 
C57BL/6 mice have been considered to be refractory to many tumors and are used in a 
wide variety of research areas including cardiovascular biology, developmental biology, 
diabetes and obesity, osteoporosis, genetics, immunology and neurobiology 
research.C57BL/6 mice have a long lifespan in conventional or specific pathogen-free 
conditions with mean life-spans of 730 to 895 day in females and 763 to 888 days in 
males (22). These mice have a long live-span and presents spontaneous lesions such as: 
Primary lung tumors 1% in males, 3% in breeding females and zero in virgin females. 
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 Lymphatic leukaemia is less than 2%, mammary and adenocarcinomas less than 
1%(23). Leukaemia 7% (24). Rare "lipomatous" hamartomas or choristomas have been 
noted (25). Susceptible to the development of atheromatous lesions on wall of aorta 
after 20 weeks on a high-fat diet(26). Develop fatty streak-like lesions in the valve sinus 
region of the ascending aorta after10-20 weeks on a diet enriched in saturated fat and 
cholesterol. Exhibit aortic cartilaginous metaplasia (contrast C3H) (27).  
 Develops noninsulin-dependent diabetes mellitus and hypertension when fed a 
high fat-high simple carbohydrate diet, whereas A/J mice do not (28). Susceptible to the 
development of atherosclerosis on a semi-synthetic high fat diet (29).  
 Blood glucose levels and insulin sensitivity in crosses between diet induced type 
II diabetes sensitive C57BL/6 and resistant A/J are genetically independent (30). High 
simple carbohydrate diet for five months induced hyperglycaemia, hyperinsulinaemia 
and hypercholesterolaemia and non-insulin-dependent diabetes mellitus which appeared 
to be associated with the metabolic characteristics of visceral fat (31). Gain more weight 
on high fat diets without consuming more calories than A/J mice and develop adipocyte 
hyperplasia. However, animals fed a low fat, high sucrose diet were leaner than those 
fed a high-complex carbohydrate diet.  
 These results suggest that genetic differences in metabolic response to fat are 
more important in the development of obesity and diabetes than caloric intake (30). 
  Loci on chromosomes 1, 3, 5 and 11 are associated with variation in high 
density lipoprotein levels with coordinate expression of cholesterol-7-alpha hydroxylase 
in a cross involving atherosclerosis resistant C3H/HeJ mice (32). Congenital 
abnormalities 10%, including eye defects, polydactyly and otocephaly (33). 
Microphthalmia and anophthalmia 8-20% and hydrocephalus 1-3% (34). Develop 
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spontaneous auditory degeneration with onset during young adulthood, with enhanced 
susceptibility to acoustic injury and delayed effects of toluene (contrast CBA/Ca) (35). 
 This is associated with early hair cell changes including bent and fused stereocilia, 
bulging of the cuticle plates, hair cell loss and swelling of affected dendrites (36). 
C57BL/6 mice carry a single recessive gene different from that found in BALB/cBy and 
WB/ReJ, causing age-related hearing loss (37). Hearing loss is caused by degeneration 
of the organ of Corti, originating in the basal, high frequency region and then 
proceeding apically over time. This results in a severe sensorineural hearing loss by 14 
months of age. More susceptible to noise-induced hearing loss than CBA/J (38). 
 
FIG.9: C57 mouse phenotype 
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EXPERIMENTAL PART 
 
4. Materials and Methods 
 
 For our studies we used 50 crosses of strain C57/BL6 mice, 35 male and 15 
female, of different ages. The mice were sacrificed by cervical dislocation, and all 
organs and tissues were macroscopically and microscopically examined. we took also 
muscle samples from triceps muscles, quadriceps femoris, cranial tibial muscle and 
heart.  
 
4.1 Light microscopy 
 
 Several sections were cut from muscle samples (10 µm thick) using the cryostat. 
The sections were stained with hematoxylin-eosin and Engel trichrome to focus on 
morphological structure and with  histoenzimatic methods such as NADH, SDH, COX, 
ATP-ase, esterase and histochemical stains such as: 
-Periodic Acid Sciff (P.A.S) to highlight the presence of mucopolysaccharides, 
-Congo-Red and Crystal Violet for the presence of beta amyloid, 
-Oil Red-O to highlight the presence of lipids, 
-Alizarin Red to show calcium deposits. 
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4.2 Immunohistochemistry 
 
 Immunohistochemistry was performed on serial transverse cryostat sections  
(5 μm thick) of muscle specimens. Immunohistochemical detection of various antigens 
was performed with avidin–biotin peroxidase complex. We used antibodies against: 
Dystrophin rod domain (clone Dy4/6D3, Novocastra Laboratories Ltd UK, diluition 1: 
50), Dystrophin c-terminus domain (clone Dy8/6C5, Novocastra Laboratories Ltd UK, 
diluition 1: 50), β-Sarcoglycan (clone, βSarc/5B1, Novocastra Laboratories Ltd UK, 
diluition 1: 100) , γ-sarcoglycan (clone 35DAG/21B5, Novocastra Laboratories Ltd UK,  
diluition 1: 100) , β-Dystroglycan (clone 43DAG1/8D5, Novocastra Laboratories Ltd 
UK, diluition 1: 100), spectrin(clone RBC2/3D5, Novocastra Laboratories Ltd 
UK,diluition 1:50), Alpha2 Laminin (mouse monoclonal antibody Clone 5H2  
MILLIPORE CA 92590 USA 1:200) aimed at highlighting proteins and membrane 
glycoproteins; Beclin-1  (BECN 1 (H300): sc-11427, Santa Cruz Biotechnology, INC, 
rabbit polyclonal, diluition  1: 300), LC3 (LC3B antibody (ab51520), Abcam, rabbit 
polyclonal, diluition 1: 3000), p62 (SQSTM- D3: sc-28359 Santa Cruz Biotechnology, 
INC, mouse monoclonal, diluition 1: 200), LAMP2 (ab37024 Abcam rabbit polyclonal, 
diluition 1: 100) for highlight the lysosomal membranes, Major Histocompatibility 
Complex class  I (H58A mouse monoclonal antibody VMRD WA 99163 USA diluition 
1: 200) and Major Histocompatibility Complex class  II(TH14B mouse monoclonal 
antibody VMRD WA 99163 USA diluition 1: 200), C5b-9 (SC5b-9 complex Ab55811, 
Abcam rabbit polyclonal, diluition 1:1000). 
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 4.3 Electron microscopy 
 
 Muscle specimens were fixed in glutaraldeide 2,5 ph for 4 hours, then washed 
several time during the day at 4 °C with phosphate buffer PH 7,4 and then, the samples 
were postfixed in 2% osmium tetroxide for 1,30 h. Then, several treatment with ethyl 
alcohol at different concentration  were made, to dehydrate the samples. We left the 
samples in absolute alcohol overnight.  
 The next day, the samples were treated with a mix of resin and absolute alcohol 
and then, these were embedded in agar resin. Ultra-thin sections were stained with and 
examined with an electron microscope. 
 
4.4 Immunoblot 
 
 From  muscle samples, cryostat sections (10 µm thick) were cut, collected in a 
1,5 ml tube, homogenized in RIPA lysis buffer containing 50 mM Hepes pH 7.5, 150 
mM sodium chloride (NaCl), 0.25% sodium deoxycholate, 1% Triton, 1 mM 
ethylenediaminetetraacetic acid (EDTA). At the time of the use we added: 20 mM 
sodium pyrophosphate (Na4P2O7), 0.1 mg/ ml aprotinin, 2 mM phenylmethylsulphonyl 
fluoride (PMSF), 10 mM sodium orthovanadate (Na2VO3), and 50 mM sodium fluoride 
(NaF) (Sigma-Aldrich, Milan, Italy) by dispenser VDI 25 (VWR, Milan, Italy). Lysates 
were clarified by centrifugation at 11,000 g for 30 minutes. Supernatants were collected 
and protein concentration was measured using the Bradford assay (Bio-Rad 
Laboratories, Milan, Italy). For Western blotting, 50 μg of lysate proteins were heated at 
100°C in 4X premixed Laemmli sample buffer. Proteins were subjected to sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) (7.5% and 15% 
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polyacrylamide) under reducing conditions. After electrophoresis, proteins were 
transferred on nitrocellulose filter membranes (GE Healtcare Life Sciences, Chalfont St 
Giles, UK) for 1h at 10 V in 192 mM glycine/25 mM Tris-HCl (pH 7.5), 10% methanol 
using a Trans-Blot SD Semy Dry cell (Bio-Rad Laboratories, Milan, Italy) according to 
the manufacturer’s instructions. 
 Blocking of non-specific binding is achieved by placing the membrane in 5% 
nonfat dry milk in Tris-buffered saline (TBS, pH 7.5) for 1 h at room temperature, 
washed with TBS-0.1% Tween. Then, filter was probed with LC3( Novus Biologicals, 
Milan, Italy) and BECN1( Novus Biologicals, Milan, Italy) antibody for an overnight 
incubation at 4°C. After three washes in Tris-buffered saline, membrane was then 
incubated with horseradish peroxidase-conjugated anti-rabbit IgG (Bio-Rad 
Laboratories, Milan, Italy) for 1 h at room temperature. After appropriate washing steps, 
bound antibody was visualized by enhanced chemiluminescence system (Western 
Blotting Luminol Reagent, Santa Cruz Biotechnology, CA, USA).  
 
4.5 Genetics 
 
 Genomic DNA was extracted from frozen muscle tissues using standard 
protocols. Briefly frozen tissue samples were homogenized with Tissue Lyser (Qiagen, 
Hilden, Germany) in TRIZOL solution and DNA was isolated by ethanol precipitation. 
The coding regions and intron-exon boundaries of the three exons were amplified by 
PCR. PCR was performed with AmpliTaq Gold with GeneAmp (Applied Biosystems, 
Foster City, CA). The reaction conditions were the followed: 10 min at 94 °C for Taq 
Gold activation, 35 cycles at 94 °C for 30 s, annealing at 62 °C for 30 s, extension at 
72°C for 60 s, and then 5 min at 72 °C. The PCR products were purified using 
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QIAquick PCR Purification Kit according to the manufacturer's instructions (Qiagen). 
Sequencing was performed with ABI 3100 sequencer at the DNA Core Facility of the 
University “Magna Graecia” and by Magabace 1000 at the GECO Laboratory of IRGS 
“G Salvatore”.   
 
5.Result 
 
5.1 Light microscopy 
 
 The sections stained with hematoxylin-eosin(fig.10), shows marked increase in 
fiber size variation, with many atrophic and some slightly hypertrophic fibers. The most 
prominent feature was presence of large vacuoles, both in the intermyofibrillar network 
and in contact with the sarcolemma. The vacuoles contained basophilic material that 
stained blue at hematoxylin-eosin or, in same case, optically clear. These vacuoles were 
seen both in the intermyofibrillar network and in contact with myofiber surface 
membranes. In sections stained with Engel's trichrome(fig.11), the vacuoles contained 
red or purple material.  
  Mosaic pattern of fiber type distribution revealed no selective fiber 
type atrophy or selectivity for vacuolar changes. The myofibrillar architecture in 
non vacuolated regions was normal; some focal densities with NADH-TR(fig.12) 
probably corresponded to reticulum modifications. The myofibrillar architecture in non-
vacuolated regions is not affected. In SDH(fig.13) and COX(fig.14) stains we observed 
several areas of loss of activities giving to the fibers a moth-eaten aspect. In all biopsies 
examined, there was no fiber necrosis, no inflammatory infiltrates, no increased 
connective or adipose tissue proliferation.  Furthermore, in all cases examined, we 
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observed no involvement of the heart muscle. Histochemical stains have ruled out that 
the vacuoles could be accumulation of amyloid or other substances such as lipids. 
The muscle fiber lipid and glycogen amount was normal. There was no autofluorescent 
pigment in the vacuoles. Some negative features were remarkable. These vacuoles were 
PAS negative. Calcium deposition was observed in several vacuoles. They occur as 
irregular deposition along the surface and were demonstrates by alizarin red. Alizarin S 
staining revealed calcium accumulations subsarcolemmally and inside vacuoles, as well 
as on the surface of some non-vacuolated fibers. Acid phosphatase activity(fig.15), 
indicative of lysosomes activities, was increased in the larger vacuoles but absent in the 
smaller ones.  However, no inflammatory infiltrate was present in our muscle samples, 
suggesting that immune inflammatory response is also blocked by the disease, with 
relevance for inflammatory muscle diseases such as polymyositis and inclusion body 
myositis. 
 
        
Fig.10 (a and b): Cross-section of XMEA skeletal muscle. The vacuoles contained 
basophilic material that stained blue at hematoxylin-eosin(arrows). 
 
20X 40X 
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Fig.11: In sections stained with Gomori's trichrome, the vacuoles contained red or 
purple material(arrows).  
        
 
 
 
         
 
 
 
40X
40X
40X 
20X 40X 
Fig.12: NADH, areas of loss of 
activities corresponding to 
vacuoles (arrows). 
Fig.13: SDH,  several areas of 
loss of activities giving to the 
fibers a moth-eaten aspect 
(arrows).
Fig.14: COX, several areas of 
loss of activities giving to the 
fibers a moth-eaten aspect 
(arrows). 
40X 
Fig.15: Esterase stain, Vacuoles 
Stain for Esterase (arrows). 
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5.2 Immunohistochemistry 
 
 Immunohistochemical findings were the same in several cases of XMEA. In 
addition to the sarcolemma, numerous vacuoles and the sarcolemmal membrane lining 
the splitting fibers were strongly immunoreactive with antibodies directed against β 
spectrin, β dystroglycan, dystrophin (ROD domain, COOH domain) (fig.16), and 
sarcoglycans but only some were immunoreactive with anti-merosin antibody.  As in 
normal controls, nuclei were strongly immunoreactive with anti-emerin antibody.  
 Some vacuoles were positive for the LAMP-2 lysosomal membrane protein 
(fig.17). While some vacuoles appeared positive for LC3, Beclina1and P62.  
Immunostaining with complement membrane attack complex (C5b9) antibody was 
positive in pathological muscle, stained strongly the vacuoles and in some fibers the 
sarcolemma. Anti-Major Histocompatibility Class I antigen (MHC-I) (fig.18) and Class 
II antigen (MHC-II) (fig.19) immunoreactivity was diffuse throughout 
the cytoplasm and sarcolemma of abnormal fibers and in some vacuoles. Normally, 
skeletal muscle does not express detectable amounts of MHC-I or MHC-II.  
 
         
 
 
 
40X
Fig.16: Anti-COOH 
(dystrophin) immunostaining. 
Vacuoles stain for Dystrophin 
Fig.17: Anti-LAMP-2 lysosomal 
membrane protein immunostaining. 
Brown spots represent LAMP- 2 
positive signals.
40X 
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5.3 Electron microscopy 
 
 At the ultrastructural investigation, the vacuoles shows a distinctive feature from 
Danon disease and other AVMs: duplication of basal lamina that surrounds the 
abnormal muscle fibers. Vacuoles are membrane-bound and contain heterogeneous 
material consisting in small round dense bodies, granular material, membrane whorls, 
degenerative mitochondria. Smaller vacuoles are present inside the myofibers, between 
myofibrils, while larger ones are seen under the sarcolemma, where they seem to open 
and extrude their content to the extracellular space; this notion is supported by the 
presence of vacuolar debris and lysosomal enzymes extracellularly between the multiple 
layers of duplicated basal lamina. 
 Ultrastructural features were similar in all cases. This material was seen between 
infolded sarcolemma and the redundant layers of basement membrane. These 
formations occupied a large portion of the muscle fiber surface. The subsarcolemmal 
vacuoles corresponded to two different types: (1) vacuoles delimited by a dual 
40X40X
Fig.18: Anti-MHC-I 
immunostaining. MHC-I signals 
on sarcolemma of abnormal 
fibers and in some vacuoles  
 
Fig.19: Anti-MHC-II 
immunostaining. Black areas 
represent MHC-II signals on 
sarcolemma of abnormal fibers 
and in some vacuoles 
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membrane with the inner membrane composed of basal lamina , and (2) autophagic 
vacuoles bounded only by a membrane. The deep sarcoplasmic vacuoles also 
corresponded to both types. The first type resulted from sarcolemmal invaginations and 
fiber splitting. The second type resulted from autophagy, because numerous electron 
dense bodies were not bounded by a membrane and were associated with T system 
proliferation. Increased triads were observed. There was no myofibrillar changes, no 
mitochondrial abnormalities, and no lipid storage.  
 In female carriers, only few muscle fibers contain autophagic vacuoles; no 
accumulation of lysosomal enzymes was seen intracytoplasmic or around sarcolemma.  
 
    
Fig.20 Electron microscopy in XMEA, electron micrographs of skeletal muscle 
biopsies from mouse showing autophagic vacuoles; Magnification 50k. 100k. 
 
5.4 Immunoblot 
 
 For western blotting analyses, we  used  antibodies against Beclin1, P62, and 
LC3 surveys in order to test the markers of autophagy.  
 We found bands at 60 kDa, 65 kDa and 15 kDa, corresponding to Beclin, P62 
and LC3  respectively. 
50K 100K 
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5.5 Genetics 
 
 VMA21 protein sequence, of 101 amminoacid residues, is highly conserved 
between human and mouse, as showed  in figure 21. In order to identify if the 
hypomorphic mutations founded in human VMA21 gene by Ramachandran et al. (11)  
are also present in the mice showing the skeletal muscle disorder we analyzed the 
complete sequence of  murine VMA21 gene. It is located on chromosome X, with three 
exons and  transcript length of 4195 base pairs (fig. 22, panel a). We made a sequence 
alignment between the human and mouse gene to allow the homology identification in 
the six single-nucleotide carrying the substitutions described for the XMEA patients. 
 We used the ClustalW2 multiple sequence alignment program for DNA 
(www.ebi.ac.uk/Tools/msa/clustalw2/). The gene alignments are showed in figure 22, 
panel b. In particular we reported the sequence of the intron-exon junctions  for exon 2 
and 3 involved in mRNA splicing efficiency, and the initial sequence of 3’UTR, 
involved in the mRNA stability. We founded two conserved nucleotide, highlighting the 
with the four nucleotide positions described by Ramachandran et al. (11) mutated in 
human gene sequence of  XMEA patients. There are ongoing sequence analysis on all 
three exons and the flanking intronic regions conducted on DNA extracted from 
affected mice and control animals to determine whether a significant association existed 
between the pathologic phenotype and the gene expression of VMA21. 
Fig.21 VMA21 mouse gene: Human and mouse protein sequence alignment 
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Fig.22 VMA21 mouse gene 
 
(A) Schematic diagram of VMA21 mouse gene, with the exons (rectangles).  The 
positions of the human corrispondig mutations are indicated by bullets. The PCR 
primer positions  are indicated by arrows (B) Human and mouse gene alignment in the 
intron-exon junctions  for exon 2, 3 indicated in red and black, respectively, and the 
3’UTR indicated in blue. The human corrispondig positions of mutations are 
underlined.  
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6. Discussion 
 
 In this thesis, we described a spontaneous mouse model of XMEA a diseases, 
first reported in 1988 by Kalimo et al.(15)  in a Finnish family, and then in a French 
family by Villanova et al.(39). 
 Genetic analysis in Kalimo's family suggested a linkage to Xq-28, although the 
lod score was not significant. 
 Multipoint linkage analysis confirmed the assignment of this locus with a 
maximal lod score of 2.74 obtained at recombination fraction zero. This was further 
confirmed recently by Auranen et al.(19) Moreover these authors assign the XMEA 
gene locus to the most telomeric 10.5 cM of chromosome X. It was demonstrated that 
the gene responsible for XMEA is a chaperone for the assembly of the organellar 
acidification pump, the vacuolar ATPase. This explains decreased acidification in 
lysosomes throughout muscle  having as a late result the formation of autophagic 
vacuoles. The main chaperone directing assembly of the V0 integral membrane domain 
of the VATPase pump  is the Vma21 protein. It was demonstrated that  vma21 deletion 
mutant (vma21Δ) has drastically reduced V-ATPases and VATPase activity in 
organellar membranes and cause X-linked myopathy with excessive autophagy.  
 XMEA mutations are hypomorphic alleles that reduce the amount of VMA21, in 
most cases by decreasing mRNA splicing efficiency. Only skeletal muscle is clinically 
affected, and only in males. Female carriers are unaffected, likely because muscle is a 
syncytium and half of the nuclei will produce normal amounts of VMA21 mRNA. 
 We analyzed the complete sequence of  murine VMA21 gene and  found that 
VMA21 protein sequence, of 101 amminoacid residues, is highly conserved between 
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human and mouse. We made a sequence alignment between the human and mouse gene 
to allow the homology identification in the the six single-nucleotide carring the 
substitutions described for the XMEA patients and we found some differences but there 
are ongoing sequence analysis to determine whether a significant association existed 
between the phathologic phenotype and the gene expression regulation of VMA21. 
  Clinically, it is difficult to define the age of disease onset due to a paucity of 
early clinical symptoms. Otherwise, childhood onset was most common. The course of 
the disease was very slow; the clinical condition remained static during the 5 years of 
observation. Moderate proximal weakness, most prominent in the lower limbs was 
noted in most cases. In some patients, muscle weakness was also present in upper 
limb girdle muscles. There was no cardiac involvement.  Among the patients reported in 
the literature, five died but the death was not myopathy related. Thus, longevity is not 
altered in most cases of XMEA. In all cases, the serum CK concentration was clearly 
elevated and usually before the onset of clinical symptoms.  
Morphological features were identical in all muscle samples, but the pathogenesis of 
the vacuole formation as well as their content remain unknown. Muscle specimens 
showed numerous vacuoles in subsarcolemmal spaces and in the intermyofibrillar 
network. Necrotic and regenerative fibers were absent. We demonstrated a marked 
deposition of the complement membrane attack complex C5b-9 on the damaged cell 
surface membrane suggesting that these deposits could be important in 
the pathogenesis of this myopathy and that the membrane bound vacuoles might be the 
consequence of sarcolemma invagination, as confirmed also with the positivity of 
dystrophin proteins on the vacuoles membrane.  In addition, we demonstrated calcium 
accumulation on sarcolemma, which is likely secondary to the membrane attack 
complex deposition on the cell surface. 
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 By EM, besides the evident features of autophagic vacuoles, we and other 
authors, observed that subsarcolemmal and intermyofibrillar vacuoles are bounded both 
by basement and sarcolemmal membranes. Moreover, immunohistochemistry showed 
that the vacuolar membranes were immunoreactive with β spectrin, 
dystrophin, sarcoglycan, and merosin. Furthermore, the invaginating sarcolemmal 
membrane also showed similar immunoreactivities. 
 In contrast, vacuolar membranes in lysosomal glycogen storage diseases did not 
express dystrophin, sarcoglycan, and merosin, although both dystrophin and β 
spectrin were previously immunolocalized to vacuolar membranes in these diseases. 
 These results strongly suggest that both autophagic activity and sarcolemmal 
invagination occurs in our cases such as in XMEA. 
As previously reported, we also observed anti-C5b-9 immunoreactivity and calcium 
deposits on the cytoplasmic membrane of all vacuolated fibers and in some non-
vacuolated fibers. Interestingly C5b-9 deposits were also present within some vacuoles. 
Thus the abnormal material accumulated within the vacuoles in XMEA corresponds to 
both calcium and C5b-9 deposits. It was previously suggested that ‘calcium 
accumulation on sarcolemma is secondary to C5b-9 deposition on the cell surface and 
could probably correspond to the calcium entering through C5b-9 channels. This 
hypothesis however should be modulated. First, not all calcium positive fibers were 
MAC positive, suggesting that calcium accumulation may precede MAC accumulation. 
Second, abnormal MAC deposition may occur without calcium deposition in a large 
number of non-necrotic muscle fibers in numerous muscular dystrophies. In our 
opinion, the cell surface membrane deposition of calcium and its abnormal 
accumulation within the vacuoles are the most salient features of this myopathy.  
 It was suggested that the primary event in XMEA is an unknown membranous 
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alteration likely affecting both plasma and T-tubule membranes leading to calcium 
deposition and MAC accumulation with subsequent membranous invagination. 
Moreover the T-tubule membrane may be involved in the formation of the autophagic 
vacuoles observed in XMEA(41). 
 Endocytosis of the MAC -positive membranes may protect the muscle fibers 
against the lytic action of the MAC. Class I and II MHC antigen were also expressed on 
the periphery of vacuoles but their expressions were not related to inflammatory 
changes. In summary, XMEA exhibits features not seen in any other muscle disease: 
persistent MAC on and calcium accumulation in non-necrotic myofibers, and 
expression of MHC class I and II antigens in the absence of any inflammation. 
Myofiber demise appears to occur through a novel form of autophagic cell death. 
 Giant autophagic vacuoles encircle sections of cytoplasm including organelles, 
proteins, glycogen, calcium-containing compartments and membrane whorls. The 
vacuoles contain lysosomal hydrolases, yet appear unable to complete digestion of their 
contents. Instead, they migrate to the myofiber surface, fuse with the sarcolemma, and 
extrude the contents extracellularly, forming a field of cell debris rich in lysosomal 
enzymes around the fiber.  
 On the other hand, XMEA mutations do not completely eliminate V-ATPase 
activity. XMEA patients do not exhibit neuro-developmental delay or clinically 
manifest skin and bone abnormalities, acidosis, or hearing loss, indicating that for the 
specialized a2, a3 and a4-containing V-ATPases the reduced V-ATPase assembly in 
XMEA does not reach a clinical threshold. 
 The literature also substantiates that decreased V-ATPase causes the autophagic 
block through raising lysosomal pH, and not through some alternate mechanism.  
XMEA is a vacuolar myopathy with a unique pathology. Understanding mechanisms 
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underlying this particular type of vacuolation and its relationship with autophagy 
progression, autophagic cell death, necrosis and inflammation is of great interest for 
future therapies not only of XMEA, but also a large number of diseases where these 
processes are affected. 
 Although the lesions of XMEA are not entirely specific, the observations 
reported in the mouse model that we studied, are similar to those described in the 
literature so far. It remains to be investigated whether this disease is caused by a 
mutation of a protein membrane-associated lysosomal sarcolemmal of a protein or a 
protein common to both membrane systems. 
 In conclusion, the unique pathological features observed in XMEA are 
characteristic and suggest a new pathophysiological mechanism.  
 Understanding the pathogenesis of this unusual type of vacuolation would not 
only help solve autophagic vacuolar myopathies and initiate appropriate therapies, but 
also give insights toward the autophagic process and its deregulation in disease. 
 Autophagy is a process whose molecular characterization is recent and on-going. 
It is relevant for a large variety of human diseases, from infections to neurodegenerative 
disorders and to cancers. 
 The availability of a well characterized mouse model, as we are proposing, it 
may help to define the etiopathogenesis of this disease and the VMA21 mutation may 
reveal the reasons for the muscle specific phenotype of XMEA. 
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